Lactoferrin - Pharming

Drug Profile

Lactoferrin - Pharming

Alternative Names: GPX 400; hLF

Latest Information Update: 30 Dec 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharming Group NV
  • Class Adjuvants; Antibacterials; Antifungals; Glycoproteins; Iron binding proteins
  • Mechanism of Action Chelating agents; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma; Bacterial infections; Cardiovascular disorders; Eye-Disorders; Haemorrhage; Hepatitis C

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 08 Mar 2005 Pharming and ProBio and Infigen have entered into an agreement for lactoferrin
  • 28 Oct 2003 Lactoferrin is no longer licensed to AM-Pharma Holding
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top